Impact of the Blood Culture Technique on the Diagnosis of Infective Endocarditis
UniEndo
1 other identifier
observational
269
1 country
8
Brief Summary
To evaluate the performance of a single high volume blood culture sampling strategy versus the actually used multiple sampling strategy for the diagnosis and categorization of infective endocarditis according to the Duke-Li classification in a Population of adults suspected of infective endocarditis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2017
Longer than P75 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 5, 2017
CompletedFirst Posted
Study publicly available on registry
May 15, 2017
CompletedStudy Start
First participant enrolled
November 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 8, 2022
CompletedMarch 19, 2024
March 1, 2024
4.5 years
May 5, 2017
March 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compared performance of a single high volume blood culture vs. multiple blood culture of usual volume for the diagnosis of infective endocarditis
Sensitivity/Specificity/Accuracy of positive bloodculture sets vs. final diagnosis assessed by the medical team (gold standard)
At the end of the hospitalization, or at the time of death if occurred during hospitalization; i.e. an average of 6 weeks after the inclusion
Secondary Outcomes (3)
Diagnostic performance of the single high volume blood culture for the diagnosis of infective endocarditis
At the end of the hospitalization, or at the time of death if occurred during hospitalization; i.e. an average of 6 weeks after the inclusion
Measuring the nursing time required for both sampling methods.
At T0, i.e. at the inclusion of the patient
Diagnosis of infective endocarditis: confirmed, possible or excluded
At the end of the hospitalization, or at the time of death if occurred during hospitalization; i.e. an average of 6 weeks after the inclusion
Study Arms (1)
one both experimental and control arm
Each patient experiences two methods of blood cultures.
Interventions
For each patient, one single high volume blood culture (3 aerobic and 3 anaerobic of 8 to 10 mL each, numbered), and then 2 samples of 16 to 20 mL (one aerobic bottle and one anaerobic for each sample).
Eligibility Criteria
Hospitalized adult patients suspected of infective endocarditis
You may qualify if:
- Patients older than 18 years
- Suspected endocarditis: Patients with Duke-Li-ESC 2015 classification as a major morphological criterion or at least two minor criteria, other than a microbiological criterion, will be considered suspicious of infectious endocarditis.
You may not qualify if:
- Antibiotherapy adapted to a situation of endocarditis, introduced more than 24 hours or stopped for less than 7 days in case of therapeutic window.
- State of consciousness not allowing loyal information.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Hôpital Nord Franche Comté
Belfort, 90000, France
Centre Hospitalier universitaire de Besançon
Besançon, 25000, France
Centre Hospitalier universitaire de Dijon
Dijon, 25000, France
Centre hospitalier Universitaire de Nancy
Nancy, 54511, France
Hopital BIchat Claude Bernard
Paris, 75018, France
Centre Hospitalier Universitaire de Reims
Reims, 51100, France
Centre Hospitalier Univesitaire de Rennes
Rennes, 35000, France
Hôpitaux Civils de Strasbourg
Strasbourg, 67000, France
Related Publications (4)
Arendrup M, Jensen IP, Justesen T. Diagnosing bacteremia at a Danish hospital using one early large blood volume for culture. Scand J Infect Dis. 1996;28(6):609-14. doi: 10.3109/00365549609037969.
PMID: 9060065BACKGROUNDDargere S, Parienti JJ, Roupie E, Gancel PE, Wiel E, Smaiti N, Loiez C, Joly LM, Lemee L, Pestel-Caron M, du Cheyron D, Verdon R, Leclercq R, Cattoir V; UBC study group. Unique blood culture for diagnosis of bloodstream infections in emergency departments: a prospective multicentre study. Clin Microbiol Infect. 2014 Nov;20(11):O920-7. doi: 10.1111/1469-0691.12656. Epub 2014 Jun 14.
PMID: 24766148BACKGROUNDThe 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3036-7. doi: 10.1093/eurheartj/ehv488.
PMID: 26590409BACKGROUNDLi JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000 Apr;30(4):633-8. doi: 10.1086/313753. Epub 2000 Apr 3.
PMID: 10770721BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François Goehringer, MD
Centre Hospitalier Universitaire de Nancy, Nancy, France
- STUDY CHAIR
Xavier Duval, MD PhD
APHP, Hôpital Bichat Claude Bernard, Paris, France.
- STUDY CHAIR
Christine Selton-Suty, MD
Centre Hospitalier Universitaire de Nancy, Nancy, France
- STUDY CHAIR
Nejla Aissa, MD
Centre Hospitalier Universitaire de Nancy, Nancy, France
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
May 5, 2017
First Posted
May 15, 2017
Study Start
November 11, 2017
Primary Completion
May 5, 2022
Study Completion
July 8, 2022
Last Updated
March 19, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share